Becker's Healthcare September 25, 2025
Oncology care company Thyme Care has raised $97 million in a Series D funding round backed by major insurers Humana and CVS Health, as well as JPMorgan’s Morgan Health division.
The round also drew support from Texas Oncology and Houston-based Memorial Hermann Health System, according to a Sept. 25 news release.
The Nashville-based startup was founded in 2020 and partners with health plans, employers, and providers to manage cancer care under value-based arrangements. Thyme said it...
Today's Sponsors
Today's Sponsor